Abstract: Disclosed are a dual modulator of mGluR5 and 5-HT2AR (5-HT2A receptor), and use thereof. More specifically, disclosed are a compound which acts as modulator of mGluR5 and an antagonist of 5-HT2AR at the same time, and use thereof as therapeutic agent for pain.
Type:
Application
Filed:
July 1, 2024
Publication date:
October 31, 2024
Applicant:
Vivozon Inc.
Inventors:
Dae Kyu CHOI, Hyo Jin KIM, Mi Seon BAE, Jin CHOI, Hyun Jin HEO, Yong Seok LEE, Geon Ho LEE, Mi Yon SHIM, Jin Sun PARK, Han Mi LEE
Abstract: Disclosed are a dual modulator of mGluR5 and 5-HT2AR (5-HT2A receptor), and use thereof. More specifically, disclosed are a compound which acts as modulator of mGluR5 and an antagonist of 5-HT2AR at the same time, and use thereof as therapeutic agent for pain.
Type:
Grant
Filed:
July 28, 2021
Date of Patent:
August 13, 2024
Assignee:
Vivozon Inc.
Inventors:
Dae Kyu Choi, Hyo Jin Kim, Mi Seon Bae, Jin Choi, Hyun Jin Heo, Yong Seok Lee, Geon Ho Lee, Mi Yon Shim, Jin Sun Park, Han Mi Lee
Abstract: A method for treating or preempting pain including postoperative pain following a soft or hard tissue surgery is disclosed. Also disclosed is a method for reducing an postoperative analgesic need, including administering a compound of Formula (I) or a salt thereof.
Abstract: Disclosed are a combination of active components inducing synergistic effects of multi-targeting and a use thereof. More particularly, disclosed are a functional food composition, a cosmetic composition, a pain-suppressive composition, and a composition for treatment or prevention of pruritus or atopic dermatitis, which comprise as active components, two or more components selected from a group consisting of (a) a 5-hydroxytryptamine subtype 2 (5-HT2) receptor antagonist; (b) a P2X receptor antagonist; and (c) any one of a glycine receptor agonist, a glycine transporter (GlyT) antagonist, a gamma-aminobutyric acid (GABA) receptor agonist, and a GABA transporter 1 (GAT1) antagonist.
Abstract: Disclosed are a novel benzamide derivative and pharmaceutical use thereof, and more particularly, a novel benzamide derivative having a structure of Formula 1 or pharmaceutically acceptable salts thereof, and a composition for prevention or treatment of pain or itching including the above material. The novel benzamide derivative and pharmaceutically acceptable salt thereof according to the present invention exhibit excellent pain-suppressive effect and, in particular, pain-suppressive effect in not only a neuropathic animal model but also other models such as a formalin model, and therefore, may be used in suppression of different pains such as nociceptive pain, chronic pain, etc.
Type:
Grant
Filed:
November 29, 2012
Date of Patent:
June 7, 2016
Assignee:
VIVOZON, INC.
Inventors:
Doo Hyun Lee, Myung Soo Ham, Ji-Hyun Lee